Benítez JM, García-Sánchez V. Faecal calprotectin: management in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2015;6:203–9.

Article  PubMed  PubMed Central  Google Scholar 

Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn’s disease. Gut. 2000;47:506–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walsham NE, Sherwood RA. Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol. 2016;9:21–9.

CAS  PubMed  PubMed Central  Google Scholar 

Pathirana WGW, Chubb SP, Gillett MJ, Vasikaran SD. Faecal Calprotectin. Clin Biochem Rev. 2018;39:77–90.

PubMed  PubMed Central  Google Scholar 

Sharma V, Verma S, Kumar-M P, et al. Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn’s disease in patients started on antitubercular therapy. Eur J Gastroenterol Hepatol. 2021;33:334–8.

Article  CAS  PubMed  Google Scholar 

Duran A, Kobak S, Sen N, Aktakka S, Atabay T, Orman M. Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis. Bosn J Basic Med Sci. 2016;16:71–4.

CAS  PubMed  PubMed Central  Google Scholar 

Jothimani D, Paramasivam R, Manoharan M, et al. Fecal calprotectin in patients of liver cirrhosis. Indian J Gastroenterol. 2023. https://doi.org/10.1007/s12664-023-01450-9.

Gundling F, Schmidtler F, Hapfelmeier A, et al. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. Liver Int. 2011;31:1406–15.

Article  CAS  PubMed  Google Scholar 

Alempijević T, Štulić M, Popovic D, Culafic D, Dragasevic S, Milosavljevic T. The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis. Acta Gastroenterol Belg. 2014;77:302–5.

PubMed  Google Scholar 

Header DA, Ellakany WI, Ellakany AI. Fecal calprotectin level as a marker of esophageal varices in Egyptian HCV cirrhotic patients. Rev Gastroenterol Mex (Engl Ed). 2022;S2255–534X(22)00083–4.

Demirbaş F, Çaltepe G, Comba A, Abbasguliyev H, Yurttan Uyar N, Kalaycı AG. Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children. Arab J Gastroenterol. 2020;21:211–5.

Article  PubMed  Google Scholar 

Matiollo C, Rateke ECM, Moura EQA, et al. Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis. World J Hepatol. 2022;14:1964–76.

Article  PubMed  PubMed Central  Google Scholar 

Fernandes SR, Santos P, Fatela N, et al. Ascitic calprotectin is a novel and accurate marker for spontaneous bacterial peritonitis. J Clin Lab Anal. 2016;30:1139–45. https://doi.org/10.1002/jcla.21994.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Honar N, Nezamabadipour N, Dehghani SM, et al. An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis. BMC Pediatr. 2022;22:382.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riva A, Gray EH, Azarian S, et al. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis. JHEP Rep. 2020;2:100151.

Article  PubMed  PubMed Central  Google Scholar 

Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: from biomarker to biological function. Gut. 2021;70:1978–88.

Article  CAS  PubMed  Google Scholar 

Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209.

Article  PubMed  Google Scholar 

Carroccio A, Iacono G, Cottone M, et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem. 2003;49(6):861–7.